Haloperidol Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg, 20 mg
Reference Brands: Haldol®(US)
Category:
Antipsychotropic Drugs
Haloperidol is a typical antipsychotic that works by blocking dopamine D2 receptors in the brain, helping to reduce positive symptoms of psychosis such as hallucinations, delusions, and disorganized thinking. Haloperidol tablets are used in the treatment of schizophrenia, acute psychosis, Tourette’s syndrome, and severe behavioral disorders, offering effective long-term symptom control through oral administration.
Haloperidol Tablets is available in Tablets
and strengths such as 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg, 20 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Haloperidol Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Haloperidol Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Haloperidol tablets are FDA-approved in the United States for treating schizophrenia, acute psychosis, and Tourette’s syndrome. In the European Union, they are authorized in various member states under national or decentralized procedures for similar psychiatric conditions. Regulatory submissions must meet GMP standards, include bioequivalence data, and provide robust safety documentation addressing risks like QT prolongation, extrapyramidal symptoms, and neuroleptic malignant syndrome. U.S. labeling must comply with FDA boxed warning requirements. EU filings must include Risk Management Plans (RMPs) and pharmacovigilance systems. To explore dossier-ready Haloperidol tablets and other forms, visit Pharmatradz.com — your trusted B2B pharmaceutical partner.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing